Inogen Inc. (INGN)

43.15
1.30 3.20
NASDAQ : Health Technology
Prev Close 41.82
Open 42.10
Day Low/High 41.53 / 43.17
52 Wk Low/High 41.19 / 287.79
Volume 144.39K
Avg Volume 514.80K
Exchange NASDAQ
Shares Outstanding 21.93M
Market Cap 925.18M
EPS 2.40
P/E Ratio 22.84
Div & Yield N.A. (N.A)

Latest News

Inogen Announces Participation In 39th Annual William Blair Growth Stock Conference

Inogen Announces Participation In 39th Annual William Blair Growth Stock Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 39 th Annual William Blair Growth Stock...

Inogen Announces First Quarter 2019 Financial Results And Updates 2019 Guidance

Inogen Announces First Quarter 2019 Financial Results And Updates 2019 Guidance

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2019.

INOGEN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against Inogen, Inc. - INGN

INOGEN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against Inogen, Inc. - INGN

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 6, 2019 to file lead plaintiff applications in a securities class action lawsuit against Inogen, Inc.

Status Quo Great for Stocks: Cramer's 'Mad Money' Recap (Friday 5/3/19)

Status Quo Great for Stocks: Cramer's 'Mad Money' Recap (Friday 5/3/19)

Jim Cramer says the economy is just right for stocks, but he's still worried about IPO froth. Here's your game plan for next week.

Inogen To Announce First Quarter 2019 Financial Results On Tuesday, May 7, 2019

Inogen To Announce First Quarter 2019 Financial Results On Tuesday, May 7, 2019

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2019 financial results after market close on Tuesday, May 7, 2019.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Inogen, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Inogen, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming  May 6, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Inogen, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Actions Against Inogen, Inc. (INGN)

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Actions Against Inogen, Inc. (INGN)

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that class action lawsuits have been filed against Inogen, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Inogen, Inc. Of Class Action Lawsuit And Upcoming Deadline - INGN

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Inogen, Inc. Of Class Action Lawsuit And Upcoming Deadline - INGN

NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inogen, Inc.

Inogen Releases Innovative Inogen One G5™ Portable Oxygen Concentrator

Inogen Releases Innovative Inogen One G5™ Portable Oxygen Concentrator

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the release to market of its innovative Inogen One G5 portable oxygen concentrator.

Hagens Berman Reminds Inogen (INGN) Investors Of May 6, 2019 Lead Plaintiff Deadline And Encourages Investors To Contact The Firm

Hagens Berman Reminds Inogen (INGN) Investors Of May 6, 2019 Lead Plaintiff Deadline And Encourages Investors To Contact The Firm

SAN FRANCISCO, April 2, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in Inogen, Inc.

Inogen Announces Participation In The 18th Annual Needham Healthcare Conference

Inogen Announces Participation In The 18th Annual Needham Healthcare Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 18 th Annual Needham Healthcare Conference in...

INGN INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Inogen, Inc.

INGN INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Inogen, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Inogen, Inc.

Lifshitz & Miller LLP Announces Investigation Of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spark Therapeutics, Inc., Stamps.com, Inc., Syneos Health, Inc., And Weight Watchers, Inc.

Lifshitz & Miller LLP Announces Investigation Of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spark Therapeutics, Inc., Stamps.com, Inc., Syneos Health, Inc., And Weight Watchers, Inc.

NEW YORK, March 22, 2019 /PRNewswire/ -- AVEO Pharmaceuticals, Inc. (AVEO) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the FDA seeking additional survival data concerning tivozanib echoing concerns...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc.; Investors With Losses In Excess Of $100K Are Encouraged To Contact The Firm - INGN

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc.; Investors With Losses In Excess Of $100K Are Encouraged To Contact The Firm - INGN

NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Inogen, Inc.

Robbins Arroyo LLP: Inogen (INGN) Sued For Misleading Shareholders

Robbins Arroyo LLP: Inogen (INGN) Sued For Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP announces that shareholders of Inogen (NASDAQ: INGN) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between November 8, 2017 and February...

INOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Inogen, Inc. - INGN

INOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Inogen, Inc. - INGN

NEW ORLEANS, March 15, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Inogen, Inc. - INGN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Inogen, Inc. - INGN

NEW YORK, March 14, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inogen, Inc.

EQUITY ALERT: Rosen Law Firm Reminds Inogen, Inc. Investors Of Important Deadline In Securities Class Action Lawsuit - INGN

EQUITY ALERT: Rosen Law Firm Reminds Inogen, Inc. Investors Of Important Deadline In Securities Class Action Lawsuit - INGN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inogen, Inc.

Investor Alert: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Inogen, Inc. - INGN

Investor Alert: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Inogen, Inc. - INGN

NEW YORK, March 7, 2019 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Inogen, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc.

Federman & Sherwood announces that on March 6, 2019, a class action lawsuit was filed in the United States District Court for the Central District of California against Inogen, Inc.

INVESTOR ALERT: Holzer & Holzer, LLC Announces Class Action Lawsuit Filed On Behalf Of Investors In Inogen

INVESTOR ALERT: Holzer & Holzer, LLC Announces Class Action Lawsuit Filed On Behalf Of Investors In Inogen

Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Inogen, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc. - INGN

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Inogen, Inc. - INGN

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Inogen, Inc.

Inogen Announces Fourth Quarter And Full Year 2018 Financial Results And Updates 2019 Guidance

Inogen Announces Fourth Quarter And Full Year 2018 Financial Results And Updates 2019 Guidance

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-month periods ended December 31, 2018.

Noteworthy Monday Option Activity: INGN, VHC, SEAS

Noteworthy Monday Option Activity: INGN, VHC, SEAS

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Inogen, Inc , where a total of 4,508 contracts have traded so far, representing approximately 450,800 underlying shares. That amounts to about 73.4% of INGN's average daily trading volume over the past month of 614,395 shares.

Inogen Announces Participation In The 8th Annual Leerink Partners Global Healthcare Conference

Inogen Announces Participation In The 8th Annual Leerink Partners Global Healthcare Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 8 th Annual Leerink Partners Global Healthcare...

Inogen To Announce Fourth Quarter And Full Year 2018 Financial Results On Tuesday, February 26, 2019

Inogen To Announce Fourth Quarter And Full Year 2018 Financial Results On Tuesday, February 26, 2019

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2018 financial results after market close on Tuesday, February...

TheStreet Quant Rating: C (Hold)